Radioactive antibody takes aim at Hard-to-Treat prostate cancer
NCT ID NCT04644770
First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 34 times
Summary
This early-phase study tests a new drug called JNJ-69086420 for men with advanced prostate cancer that has spread and is no longer responding to hormone therapy. The drug is an antibody linked to a radioactive particle that targets a protein found on prostate cancer cells. The study aims to find the safest dose and check for side effects and early signs that the drug is working.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATIC NEOPLASMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Case Western Reserve University
Cleveland, Ohio, 44106, United States
-
City of Hope
Duarte, California, 91010, United States
-
East Jefferson General Hospital
Metairie, Louisiana, 70006, United States
-
Mayo Clinic Arizona
Phoenix, Arizona, 85054, United States
-
Mayo Clinic Rochester
Rochester, Minnesota, 55905, United States
-
Mayo Clinic in Florida
Jacksonville, Florida, 32224, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Tulane University Hospital & Clinics
New Orleans, Louisiana, 70112, United States
-
University of Chicago
Chicago, Illinois, 60637, United States
-
University of Utah Huntsman Cancer Institute
Salt Lake City, Utah, 84112, United States
-
XCancer Omaha / Urology Cancer Center
Omaha, Nebraska, 68130, United States
Conditions
Explore the condition pages connected to this study.